HCA - HCA Healthcare, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$455.19
DETAILS
HIGH:
$579.00
LOW:
$369.00
MEDIAN:
$442.50
CONSENSUS:
$455.19
UPSIDE:
8.94%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Dalio | 203,204 | $79.2M | 0.3% | +29,403 | INCREASED |
| Cooperman | 139,447 | $54.4M | 0.0% | +89,512 | INCREASED |
| Greenblatt | 55,472 | $21.6M | 0.1% | -3,867 | DECREASED |
| Wood | 11,500 | $4.5M | 0.0% | +1,500 | INCREASED |
| Halvorsen | 0 | $0 | -- | -1,075,133 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-26 | McAlevey Michael R | officer: EVP & Chief Legal & Admin Off. | J-Other | 7,769 | $429.00 | $3.3M |
| 2026-05-07 | Marks Mike A | officer: EVP and CFO | G-Gift | 3,336 | -- | -- |
| 2026-04-28 | MICHELSON MICHAEL W | director | A-Award | 925 | -- | -- |
| 2026-04-28 | DEPARLE NANCY ANN | director | A-Award | 509 | -- | -- |
| 2026-04-28 | FRIST THOMAS F III | director, 10 percent owner: | A-Award | 1,041 | -- | -- |
| 2026-04-28 | CHIDSEY JOHN | director | A-Award | 809 | -- | -- |
| 2026-04-28 | Frist William R | director, 10 percent owner: | A-Award | 809 | -- | -- |
| 2026-04-28 | Smith Andrea B | director | A-Award | 509 | -- | -- |
| 2026-04-28 | Johnston Hugh F | director | A-Award | 809 | -- | -- |
| 2026-04-28 | Riley Wayne Joseph | director | A-Award | 509 | -- | -- |
| 2026-02-18 | McAlevey Michael R | officer: EVP & Chief Legal & Admin Off. | SELL | 1,694 | $533.37 | $904K |
| 2026-02-13 | McAlevey Michael R | officer: EVP & Chief Legal & Admin Off. | M-Exempt | 5,000 | $236.61 | $1.2M |
| 2026-02-13 | McAlevey Michael R | officer: EVP & Chief Legal & Admin Off. | F-InKind | 3,306 | $540.29 | $1.8M |
| 2026-02-10 | Marks Mike A | officer: EVP and CFO | F-InKind | 1,690 | $502.05 | $848K |
| 2026-02-10 | Wyatt Christopher F. | officer: SVP & Controller | A-Award | 3,350 | -- | -- |
| 2026-02-10 | Rossitto Erica | officer: SVP & Chief Nurse Executive | F-InKind | 418 | $502.05 | $210K |
| 2026-02-10 | Marks Mike A | officer: EVP and CFO | A-Award | 5,026 | -- | -- |
| 2026-02-10 | Cuffe Michael S. | officer: EVP and Chief Clinical Officer | A-Award | 9,628 | -- | -- |
| 2026-02-10 | Foster Jon M | officer: EVP and COO | F-InKind | 5,888 | $502.05 | $3.0M |
| 2026-02-10 | Wyatt Christopher F. | officer: SVP & Controller | F-InKind | 1,034 | $502.05 | $519K |
| 2026-02-10 | Berres Jennifer | officer: SVP & Chief Human Res. Officer | F-InKind | 2,515 | $502.05 | $1.3M |
| 2026-02-11 | Wyatt Christopher F. | officer: SVP & Controller | SELL | 4,000 | $505.00 | $2.0M |
| 2026-02-10 | Foster Jon M | officer: EVP and COO | A-Award | 15,696 | -- | -- |
| 2026-02-10 | Berres Jennifer | officer: SVP & Chief Human Res. Officer | A-Award | 7,116 | -- | -- |
| 2026-02-10 | Rossitto Erica | officer: SVP & Chief Nurse Executive | A-Award | 1,676 | -- | -- |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-08-14 | William R. Keating | HOUSE | Purchase | $15,001 - $50,000 |
| 2026-07-27 | Jared Moskowitz | HOUSE | Purchase | $1,001 - $15,000 |